ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,748Medicare Part D Prescriptions Filled, Including Refills

Rank: 468 out of 2888

$494K Total Retail Price of All Prescriptions

Rank: 860 out of 2888

480 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 480 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 8,786 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
FUROSEMIDE 413 389 1 6
LEVOTHYROXINE SODIUM 381 309 2 1
HYDROCODONE-ACETAMINOPHEN 371 289 S3 3 4
POTASSIUM CHLORIDE 334 290 4 14
SIMVASTATIN 324 256 5 2
AMLODIPINE BESYLATE 303 245 6 5
OMEPRAZOLE 277 215 7 7
LISINOPRIL 251 196 8 3
WARFARIN SODIUM 225 208 9 22
TRAMADOL HCL 217 202 10 16
METFORMIN HCL 193 132 11 8
METOPROLOL TARTRATE 185 154 12 10
GABAPENTIN 175 117 13 13
CARVEDILOL 166 163 14 21
MIRTAZAPINE 163 163 15 54
CIPROFLOXACIN HCL 122 104 16 47
DONEPEZIL HCL 122 117 16 26
HYDROCHLOROTHIAZIDE 120 70 18 15
DIGOXIN 118 105 19 55
CITALOPRAM HBR 117 68 20 24
ISOSORBIDE MONONITRATE ER 115 113 21 51
PREDNISONE 105 94 22 42
QUETIAPINE FUMARATE 105 100 22 66
GLIPIZIDE 100 88 24 50
NAMENDA 91 87 25 34
FAMOTIDINE 89 85 26 75
ALLOPURINOL 88 87 27 37
TRAZODONE HCL 88 87 27 43
SERTRALINE HCL 87 75 29 27
MELOXICAM 86 61 30 31
CLOPIDOGREL 85 57 31 30
LOSARTAN POTASSIUM 85 52 31 18
TAMSULOSIN HCL 83 79 33 29
OXYBUTYNIN CHLORIDE 77 77 34 124
NEXIUM 76 52 35 19
NOVOLIN R 76 73 35 109
PRAVASTATIN SODIUM 72 58 37 12
METOPROLOL SUCCINATE 67 65 38 11
VENLAFAXINE HCL 66 66 39 246
HYDRALAZINE HCL 64 51 40 59
GLIMEPIRIDE 64 48 40 36
METOCLOPRAMIDE HCL 64 63 40 116
MEGESTROL ACETATE 63 63 R 43 140
CLONIDINE HCL 63 54 43 39
PROAIR HFA 61 35 45 71
PLAVIX 61 40 45 40
AMITRIPTYLINE HCL 60 55 R 47 74
DIVALPROEX SODIUM 57 47 48 100
LANTUS 56 53 49 45
ZOLPIDEM TARTRATE 55 48 50 17
RISPERIDONE 55 43 50 72
ESCITALOPRAM OXALATE 54 42 52 62
VENLAFAXINE HCL ER 54 37 52 120
RAMIPRIL 53 53 54 73
METOLAZONE 51 50 55 215
PANTOPRAZOLE SODIUM 50 41 56 33
GLYBURIDE 50 15 R 56 58
ATENOLOL 50 25 56 25
POLYETHYLENE GLYCOL 3350 50 49 56 93
NITROGLYCERIN PATCH 50 38 56 183
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.